Načítá se...
cGMP modulation therapeutics for sickle cell disease
Sickle cell disease (SCD) is an inherited disease caused by the production of abnormal hemoglobin (Hb) S, whose deoxygenation-induced polymerization results in red blood cell (RBC) sickling and numerous pathophysiological consequences. SCD affects approximately 300,000 newborns worldwide each year a...
Uloženo v:
| Vydáno v: | Exp Biol Med (Maywood) |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publications
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6405827/ https://ncbi.nlm.nih.gov/pubmed/30691292 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1535370219827276 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|